A health and wellness investment opportunity spanning multiple revenue streams.
Delic Holdings Inc is focused on bringing psychedelic wellness to the mainstream. It does this through an umbrella of related businesses it owns and operates to support scaling the impact and reach of treatment, including:
- trusted media and e-commerce platforms and in-person events to market the services directly to patients and consumers and gain data.
- a licensed lab to develop IP, R&D, and innovative high-quality and safe product lines.
- the largest and most accessible network of physical clinics to administer effective treatments.
Psychedelic wellness company Delic Holdings Inc is home to a growing array of consciousness-enhancing wellness assets.
With these tools in hand, the company is on a mission to better inform the public of all the good that can come from better understanding the hallucinogenic space.
For investors, this presents an exciting opportunity to invest in a promising growth story with real-world earning power.
Along with its research lab, website, blog, podcast, e-commerce store, and elaborate in-person events, Delic Corp is expanding to the largest chain of profitable treatment and wellness clinics in the world, while simultaneously conducting scientific research.
The future of hallucinogens will cater to a significant consumer packaged goods and products market — and its lab will allow it to serve that audience.
Delic Corp Labs develops IP and novel psychedelic products. It embraces licensing opportunities and works with other legal companies in biotech, and other progressive sectors, to develop increasingly effective products and treatments.
All of the above translates into money-spinning potential with a feel-good karmic quality.
Tackling mental health
Mental health problems have been rising in recent years, and Covid-19 has accelerated this trend.
21% of US adults now live with high levels of psychological distress. Unfortunately, younger generations are suffering the most, with 32% of these aged 18 to 29.
While conventional medicine has its place, it comes with an assortment of unwanted side effects.
Worse still, between 40% and 71% of patients taking antidepressants relapse.
The world is crying out for a viable solution, and this is where Delic Corp is poised to help.
A trusted chain of treatment clinics
Delic Corp is focused on bringing the most patients into a safe space and increasing accessibility to its clinics. With the close of a pending acquisition, it will operate the largest network of health clinics that currently offer ketamine treatment, which has shown great success with a number of significant mental health conditions. As future substances are FDA approved, it will provide those as well through its clinics.
It does not believe telehealth or remote health efforts to treat mental health conditions are as effective as personalized in-person clinical treatments with…